Synergistic Fabrication of Dose-Response Chitosan/Dextran/β-Glycerophosphate Injectable Hydrogel as Cell Delivery Carrier for Cardiac Healing After Acute Myocardial Infarction.

Dose Response · 2020 · PMC7457666 · PMID 32922226

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

practically significantno p-value reported

Regarding to overcome this problem, experimentally and practically significant risk heart transplantation is only obligatory treatment for AMI.

also in 1,558 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.